For example, treatment with propranolol, a β1- and β2-AR antagonist, attenuates cancer growth, both in preclinical models of melanoma and in patients with melanoma, suggesting that β-AR stimulation may regulate melanoma growth [4,6,7,8,9,10,11,12]. The gene discussed is ADRB2; the disease is melanoma.